Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination.

[1]  R. Silver,et al.  A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan). , 1994, The Journal of clinical investigation.

[2]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[3]  H. Kita,et al.  Materials and Methods Brief Definitive Report Granulocyte/macrophage Colony-stimulating Factor and Interleukin 3 Release from Human Peripheral Blood Eosinophils and Neutrophils , 2022 .

[4]  A. Engel,et al.  Eosinophilia myalgia syndrome: I. Immunocytochemical evidence for a T‐cell–mediated immune effector response , 1991, Annals of neurology.

[5]  A. N. Mayeno,et al.  Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome. , 1990, Science.

[6]  J. Abrams,et al.  Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. , 1990, Journal of immunology.

[7]  J. Elias,et al.  Human alveolar macrophage and blood monocyte interleukin-6 production. , 1990, American journal of respiratory cell and molecular biology.

[8]  M. Dalakas,et al.  L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. , 1990, The Journal of clinical investigation.

[9]  M. Osterholm,et al.  An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. , 1990, The New England journal of medicine.

[10]  A. Limaye,et al.  Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients , 1990, The Journal of experimental medicine.

[11]  G. Gleich,et al.  Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. , 1990, The New England journal of medicine.

[12]  R. Kyle,et al.  IgA-induced eosinophil degranulation. , 1989, Journal of immunology.

[13]  J. Banchereau,et al.  Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. , 1989, Journal of immunological methods.

[14]  J. Banchereau,et al.  Epitope mapping of recombinant human gamma interferon using monoclonal antibodies. , 1989, Molecular immunology.

[15]  M. V. Doyle,et al.  Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2. , 1985, Journal of biological response modifiers.

[16]  D. Storm,et al.  Polymyxin and related peptide antibiotics. , 1977, Annual review of biochemistry.